iPSC-derived Neuron and Neural Progenitor Cell (NPC) Generation Services
Human neurons and neural progenitor cells (NPCs) are invaluable models and useful tools for disease mechanism exploration and drug screening. However, obtaining those primary cells poses several challenges, including ethical considerations, limited availability of human tissue, and the difficulty of isolating and maintaining these cells in vitro. The advent of induced pluripotent stem cells (iPSCs) reprogramming technology has overcome this limitation, making the generation of various neurons both easy and efficient. Leveraging our expertise in this cutting-edge field, we are proud to offer researchers the iPSC-derived neurons and neural progenitor cells that facilitate groundbreaking studies in neuroscience.
What We Can Provide
iPSC-derived GABAergic Neuron Generation | iPSC-derived Glutamatergic Neuron Generation |
iPSC-derived Cortical Neuron Generation | iPSC-derived Motor Neuron Generation |
Overview of iPSC Technology
iPSCs are somatic cells reprogrammed to an embryonic stem cell-like state through the introduction of specific transcription factors. The resulting iPSCs retain the ability to differentiate into nearly any cell type in the body, including neurons and neural progenitor cells, which serve as the precursors for mature neurons. By providing a renewable source of these specialized cells, iPSC technology offers significant advantages over traditional methods, such as the use of embryonic stem cells or primary neurons, which can be limited in availability and ethical considerations.
Derivation of Neurons and Neural Progenitor Cells
The process of generating neurons and NPCs from iPSCs typically involves several stages:
1. Reprogramming Somatic cells (e.g., skin or blood cells) are collected and reprogrammed into iPSCs using defined factors, usually via viral or non-viral methods. This step is crucial as it ensures the pluripotency of the derived cells. |
2. Differentiation Once established, iPSCs are directed to differentiate into neural progenitor cells through the application of specific signaling molecules and growth factors in a controlled environment. This often mimics the natural conditions found during early brain development. |
3. Maturation Neural progenitor cells can further differentiate into mature neurons or glial cells. This maturation process involves the induction of neuronal identity through various biochemical cues and may require several weeks to months for the cells to reach functional maturity. |
Fig.1 NPCs were derived from iPSCs, and these NPCs were subsequently induced to differentiate into neurons.1
Applications and Importance
- Disease Modeling
hiPSC-derived neurons and NPCs play a pivotal role in advancing neurological research and drug discovery. Their ability to model neurological diseases, such as Alzheimer's and Parkinson's, provides invaluable insights into disease mechanisms and potential therapeutic targets.
- Drug Screening
Furthermore, hiPSC-derived neurons and NPCs enable high-throughput screening of drug candidates, facilitating the identification of neuroprotective compounds. Their use in cellular therapies holds promise for regenerative medicine, potentially offering new treatments for neurodegenerative disorders.
Contact Us Today
Unlock the potential of hiPSC-derived neurons for your research needs. Contact us today to learn more about our services and how we can support your research goals.
Reference
- Kang, S., Chen, X., Gong, S. et al. "Characteristic analyses of a neural differentiation model from iPSC-derived neuron according to morphology, physiology, and global gene expression pattern". Sci Rep 7, 12233 (2017), Distributed under CC BY 4.0, without modification.
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1683) (Cat#: NRP-0422-P1683)
- iNeuMab™ Anti-GD2 Antibody (NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P517) (Cat#: NRP-0422-P517)
- iNeuMab™ Anti-pTau Antibody (NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- iNeuMab™ Anti-FGFR1 Antibody (NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- iNeuMab™ Anti-TREM2 BBB Shuttle Antibody (NRZP-1022-ZP4114) (Cat#: NRZP-1022-ZP4114)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Rat Muller Cell (Cat#: NCL2110P040)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- Mouse Glioma Cell Line GL261 (Cat#: NCL-2108P28)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)